Quick Answer
UTAH MEDICAL PRODUCTS INC reported Cash and Equivalents of $85.76 million for fiscal year 2025.
UTAH MEDICAL PRODUCTS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $85.76M | +3.4% |
| 2024 | $82.98M | -10.7% |
| 2023 | $92.87M | +23.7% |
| 2022 | $75.05M | +23.1% |
| 2021 | $60.97M | +18.2% |
| 2020 | $51.59M | +20.6% |
| 2019 | $42.79M | -16.3% |
| 2018 | $51.11M | +28.2% |
| 2017 | $39.88M | +51.6% |
| 2016 | $26.30M | +13.0% |
| 2015 | $23.28M | +20.8% |
| 2014 | $19.27M | +33.9% |
| 2013 | $14.39M | +62.3% |
| 2012 | $8.87M | +35.8% |
| 2011 | $6.53M | +71.1% |
| 2010 | $3.82M | +831.2% |
| 2009 | $410.0K | +322.7% |
| 2008 | $97.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $84.27M | -4.7% | +2.5% |
| June 30, 2025 | $82.18M | -7.9% | -1.4% |
| March 31, 2025 | $83.33M | -11.2% | +0.4% |
| December 31, 2024 | $82.98M | -10.7% | -6.2% |
| September 30, 2024 | $88.45M | +0.3% | -0.9% |
| June 30, 2024 | $89.22M | +5.4% | -4.9% |
| March 31, 2024 | $93.81M | +15.9% | +1.0% |
| December 31, 2023 | $92.87M | +23.7% | +5.3% |
- UTAH MEDICAL PRODUCTS INC showed an increase of +3.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, UTAH MEDICAL PRODUCTS INC’s cash and equivalents has grown by 88308.2% (from $97.0 thousand to $85.76 million).
- The most recent figure is from UTAH MEDICAL PRODUCTS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: